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PREVALENCE OF ANTIBODIES AGAINST HEPATITIS A VIRUS AMONG THE KUIKURO AND KAIABI
INDIANS OF XINGU NATIONAL PARK, BRAZIL
Manuel Mindlin LAFER, Maria Isabel DE MORAES-PINTO & Lily Yin WECKX
SUMMARY
A seroprevalence study to detect total antibodies against Hepatitis A Virus was done with 220 samples from 589 Native Indians
from Xingu National Park, Brazil, in five Kaiabi and Kuikuro villages, the most populous ethnic groups. Using a commercial
immunoassay kit we detected 97.7% positive samples (95% Confidence Interval: 95%-99%). We noticed a precocious seroconversion,
before the age of six years, when the disease is usually asymptomatic. These results are similar to those found in the literature in
non-Indian population studies of the Northern, Northeastern and West Central regions of Brazil. They suggest that it is not necessary
to introduce vaccination against Hepatitis A in these highly endemic populations.
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INTRODUCTION
Hepatitis A is caused by the RNA Picornaviridae Hepatitis A Virus,
transmitted predominantly by the fecal-oral route. It is a disease of universal
distribution, with different degrees of endemicity - high, intermediate,
low and very low - varying in geographic regions according to
socioeconomic, hygiene and health conditions15,17. Hepatitis A may be
asymptomatic or symptomatic - with or without ictericia. Asymptomatic
infections predominate in infants and children. It is predominantly acute -
without sequelae. In 1% of the acute cases, however, fulminant fatal
hepatitis can occur if not treated with liver transplantion17,19. Fulminant
Acute Hepatitis A is in fact one of the indications for hepatic transplantation
in Brazil21. Unusually, benign relapse, non-cirrhotic cholestasis, aplastic
anemia and autoimmune disease can occur17,19.
In highly endemic regions, infection usually occurs before the age
of five years; it is either mildly symptomatic or asymptomatic, and
there is a lower risk of outbreaks and epidemics. These characteristics
change where socioeconomic and hygiene conditions improve:
endemicity is reduced and the age of infection increases7,15. Lifelong
immunity follows infection, and IgG antibodies against Hepatitis A
Virus are usually present one to four weeks after the clinical
symptoms19.
Hepatitis A seroprevalence studies in Brazil have shown different
rates according to the period when sera were collected, but also to the
socioeconomic background of the communities analyzed3,8,10,11,16,18,20,23.
Vaccination was suggested to interrupt the ongoing outbreaks that
occur every five to 10 years in communities where there was a 30% to
40% seroprevalence before the age of five years. This was the case
with the American Indians, among whom a maintained reduction of
the high rates of the disease was possible with the introduction of
Hepatitis A vaccine7. The vaccine has also been adopted in Israel, with
a favorable cost-bennefit analysis9,13 and herd effect protection9. More
recently, it has also been adopted in Argentina2 and the United States7.
The Brazilian Ministry of Health adopts an adapted and larger than
the general vaccination schedule for Indian populations6. This schedule
does not include vaccination against Hepatitis A Virus, partially due to
the lack of recent studies5,12,15 in these populations to evaluate this need
and justify the adoption of that measure. Therefore, our aim was to
estimate the Hepatitis A seroepidemiology in a West Central bordering
Northern region in Brazil, a geographically and culturally well defined
Indigenous population territory.
MATERIAL AND METHODS
This study was performed between June and September 2001 at
the Xingu Indigenous National Park, a 2,642,003 hectare area, located
in the North of the Mato Grosso State, with a population of 3,919
inhabitants, as described elsewhere14. The research protocol was
submitted to and approved by the Ethics Committee of the Federal
University of São Paulo (UNIFESP) and by the National Ethics
Committee of the Brazilian Ministry of Health. Written consent was
obtained from the Park leaders, the community chiefs and the
Indigenous health agents. Oral consent was obtained from all the
subjects. We evaluated 220 individuals over one year old from a total
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of 589 Native Indians from the Kuikuro and Kaiabi tribes. The villages
assessed were the “Afukuri” and “Kuikuro” in the Southern region of
the Park, where the Kuikuro Indians are located; in the Northern region,
the “Capivara”, “Guarujá” and “Tuiararé” villages, where the Kaiabi
Indians live.
In both ethnic groups, the Kuikuro and the Kaiabi Indians, despite
important cultural and linguistic differences, we found a similar circular
disposition of the houses and health conditions. The number of houses
in each Kaiabi village was: nine in the “Capivara” village, seven in
“Guarujá” and 24 in “Tuiararé”. In the Kuikuro villages, it was 10 in
“Afukuri” and 20, in the “Kuikuro” village. The mean of inhabitants in
each house in the five villages ranged from five to 12.
Two hundred and twenty blood samples of 3 mL each were
collected, according to the following criteria: one in two individuals
below 20 years old and one in every four individuals above 20 years
old. We did not analyze children below one year due to the possibility
of false positive results because of the presence of maternal antibodies.
Serum was separated and sent to the Research Laboratory of the
Pediatric Infectious Diseases Division of the Federal University of
São Paulo, where it was kept at -20 oC until analysis.
Results were obtained with a competitive immunoenzymatic assay
using commercial kits BioRad®, produced by DiaSorin (Italy).
Concentrations of antibodies 20 mIU/mL or greater were considered
to be protective1.
Statistical analysis was performed using Microsoft Excel® 2000.
Probabilities were assessed for 95% significance and Fleiss’ test was
used to obtain more accurate confidence intervals of values close to
100% seroprevalence.
RESULTS
The prevalence of anti-HAV total antibodies found was 97.7% (95%
Confidence Interval: 95%-99%) in the 220 samples from individuals
over one year old. The ages of the five seronegative individuals were:
two years (two individuals), three, four and six years; two of them
belonged to the two Kuikuro Indians villages and the other three, to an
unique Kaiabi village, the “Capivara” village. Serology results
according to age groups are shown in Table 1.
DISCUSSION
The results show a high seroprevalence of Hepatitis A in the
Indigenous population of the Xingu National Park with a precocious
onset. In fact, in high endemicity areas, infection occurs in the five
first years of life, with few if any symptoms1,8,15. Data is also compatible
with the 98% seroprevalence of hepatitis A among 352 Xicrin Indians15,
among Parakanã and Asurini populations - 100% (n = 58)5 - and with
the 96.6% seroprevalence found among the Katukinos of the occidental
Amazon region, obtained from 32 individuals12.
All the assessed villages were located next to a river, from which
the water supply came. The only exception being the “Kuikuro” village,
which was close to a river, but had an artesian well dating from the
year 2000. Every house in every village owned its cesspit. Each village
had places to collect, burn and bury garbage, but the use of such places
did not avoid the presence of garbage in inappropriate areas. Hand
washing before meals or handling food by these indigenous groups
may be less frequent than desired.
In North American Indian populations one study published in 1986
found a 70.1% seroprevalence of antibodies anti-HAV22, a high
prevalence when compared to the United States’ 45% seroprevalence
in the adult population at that time, and is probably due to poorer
sanitary conditions. However, immunization against Hepatitis A reduced
the prevalence of the disease among American Indian and Alaskan
natives4.
In Brazil, one study showed a total prevalence of 66.59% in the
city of São Paulo11. Another study published in 2000 showed a 64.7%
seroprevalence of hepatitis A in four different regions, in urban
populations. In this study the 6-10 year group showed a 53.9%
seroprevalence. Interestingly, only in the 11-15 year group the plato
prevalence of 60.7% was reached, showing that infection still occurred
after the age of 10. Of note was the especially high result in the Northern
region (92.8%)8 when analyzed separately (data from the Central region
was not avaliable).
Other studies performed in the Southeastern region of Brazil have
shown lower seroprevalence rates, especially when groups with higher
socioeconomic status were analyzed10,20,23. By contrast, studies
performed in the Northern region showed a 86.4% seroprevalence of
hepatitis A among children from two to nine years (n = 487)3, and
90.9% in riverine children from 0 to 10 years old (n = 22)16.
The precocious hepatitis A seroconversion observed in our study
(93% in the one to five year age group) does not suggest the need to
introduce vaccination against the disease in native Indians from Xingu
National Park: it would not prevent epidemics or the severe form of
the disease that occurs in adolescents and adults.
RESUMO
Prevalência de anticorpos contra o vírus da hepatite A entre os
índios Kuikuro e Kaiabi do Parque Indígena do Xingu, Brasil
Um estudo de soroprevalência para detectar anticorpos totais contra
o Vírus da Hepatite A foi realizado com 220 amostras obtidas de 589
indivíduos de cinco aldeias indígenas das tribos Kaiabi e Kuikuro, as
Table 1
Total antibodies against hepatitis A virus according to age group in Brazilian
Indigenous Communities from Xingu National Park
Samples
Age group N Positive Percentage 95% Confidence
(years) Interval
1 to 5 64 60 93.7 83-97
6 to 10 57 56 98.2 91-100
11 to 15 38 38 100.0 91-100
16 to 20 35 35 100.0 90-100
21 or more 26 26 100.0 87-100
Total 220 215 97.7 95-99
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mais populosas do Parque Nacional do Xingu, Brasil. Utilisando um
kit comercial de ensaio imunoenzimático, detectamos 97,7% amostras
positivas (Intervalo de Confiança de 95%: 95%-99%), com uma
soroconversão precoce, antes dos seis anos de idade, quando a doença
costuma ser assintomática. Estes resultados são semelhantes aos
resultados encontrados na literatura em estudos com populações não-
indígenas das regiões Norte, Nordeste e Centro-Oeste do Brasil, e sugere
que não há necessidade de introdução de vacinação contra Hepatite A
nestas populações de alta endemicidade.
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